Cognizin Citicoline Dosing in a Healthy Adolescent Male Population
This trial is active, not recruiting.
|Treatments||citicoline, microcrystalline cellulose|
|Start date||June 2012|
|End date||September 2016|
|Trial size||84 participants|
|Trial identifier||NCT01582113, IRB_49504|
To determine the functional effects of Citicoline, a natural supplement, when administered for a duration of four weeks (28 days) to non-psychiatric adolescent male participants. The investigators hypothesize that citicoline will provide cognitive benefits to this population after 28 days of supplementation.
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
|Masking||double blind (subject, investigator, outcomes assessor)|
time frame: 28 days
Male participants from 13 years up to 18 years old.
Inclusion Criteria: - Male - Age 13-18 years old - No history of co-morbid psychiatric disorder, current Axis I or II diagnosis or previous pharmacotherapeutic trial Exclusion Criteria: - Head injury with LOC > 5 minutes - Use of any psychotropic medication
Call for more information